Çetin Ordu: New Study Supports Genomic Testing in Early-Stage Breast Cancer

Coverage, in order

1. 6h ago
   
   OncoDaily obscure study

   Çetin Ordu: New Study Supports Genomic Testing in Early-Stage Breast Cancer

   Çetin Ordu, Professor of Medical Oncology at Demiroğlu Bilim University, shared on LinkedIn: “The Oncotype DX Recurrence Score (ODX RS), which was previously found to be cost-effective based on the

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.